-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
An overview video of Volition and our mission to advance the science of epigenetics.
Volition is developing and commercializing simple, easy to use, cost effective blood tests to help diagnose and monitor a range of diseases including some cancers and diseases associated with NETosis, such as sepsis.
Find our more about Nu.Q® – our nucleosome quantification technology.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields